Corticosteroids Flashcards
(45 cards)
Adrenocorticoids
Glucocorticoids
Mineralcorticoids
Glucocorticoids
Stress hormones
Increase circulating glucose concentrations
Potent anti-inflammatory effects
Mineralocorticoids
Na+ retention
Increase blood volume
Increase blood pressure
T/F: Epinephrine and Cortisol contrast each other
True
Adrenal insufficiency other name
Hypoadrenalism - Decreased secretion of steroid hormones by the adrenal cortex
Adrenal insufficiency causes
Destruction of the cortex by tuberculosis or atrophy (primary: Addison’s disease)
-Decreased secretion of ACTH due to diseases of anterior pituitary (secondary; no hypoaldosteronism
Adrenal insufficiency symptoms
Extreme weakness
Anorexia, anemia, nausea, vomiting
Low blood pressure (in primary only)
Mental depression
Cessation of long-term systemic glucocorticoid therapy can lead to
Addisonian symptoms
Cushing’s disease other name
Hyperadrenalism
Cushing’s disease causes
Tumors in the adrenal cortex (adrenal)
Increased production of ACTH due to non-pituitary carcinoma (pituitary)
Ectopic production of ACTH due to non-pituitary carcinoma (ectopic)
Cushing’s disease causes
Increased protein catabolism (easy bruising, wound healing, muscle wasting) increased glucose levels
Osteoporosis
opportunistic infections
Long-term therapeutic use of systemic glucocorticoids can lead to
Cushing’s symptoms
Change of cortisol to cortisone
OH on 11 is changed to ketone on 11
T/F: the conversion of cortisol to cortisone is reversible
True
T/f: cortisone is effective as cortisol, when used systemically
True
T/F: Cortisone should be used in patients with impaired liver function
False
Short acting systemic corticosteroids (8-12 hrs)
Hydrocortisone
Cortisone
Intermediate acting systemic corticosteroids (12-36hrs)
Prednisone
Prednisolone
Methylprednisolone
Traimcinolone
Long-acting systemic corticosteroids (36-54 hrs)
Dexamethasone
Betamethasone
Fludrocortisone
Synthetic glucocorticoid
9a-F
Greater glucocorticoid activity
Strong mineralocorticoid activity
Intense Na+ retention leading to edema
Used in mineralocorticoid replacement therapy
(ADDITION OF F)
(intermediate)
Prednisone/Prednisolone
Synthetic Glucocorticoids
Extra double bond between CI and C2
Altered ring structure
More potent glucocorticoid activity
Stronger binding to the glucocorticoid receptor
Reduced mineralocorticoid activity
Interconvertible by 11B hydroxysteroid dehydrogenase
(DOUBLE BOND ON THE TOP OF FIRST RING)
(intermediate)
Methylprednisolone
Synthetic glucocorticoids
6a-methyl group
Potency similar to that for prednisolone
Reduced mineralocorticoid activity
(ADDITION OF METHYL ON CARBON 6)
(Intermediate)
Triamcinolone
Synthetic glucocorticoids
9a-F and 16a-OH
Glucocorticoid activity similar to prednisone
Reduced mineralocorticoid activity
Increased hydrophilicity
Low oral bioavailability
(F AND OH)
(intermediate acting)
Dexamethasone
16a-methyl group
Increased lipophilicity
Increased receptor binding
Significantly stronger effect
Increased stability in human plasma
Reduced mineralocorticoid activity
(Long duration)